CTLA4 and metastatic melanoma: In fact, antagonists of immune checkpoint molecules such as cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed cell death protein 1 (PD-1) have been used for the treatment of unresectable or metastatic melanoma (15).